Catalogo Prodotti UNIBA

Catalogo Prodotti UNIBA: [143468] Home page macrotipologia

Sfoglia

N.D. 0

1 Contributo su Rivista 84231
- 1.1 Articolo in rivista 77213
- 1.2 Recensione in rivista 2113
- 1.3 Scheda bibliografica 497
- 1.4 Nota a sentenza 951
- 1.5 Abstract in rivista 3287
- 1.6 Traduzione in rivista 170

2 Contributo in Volume 24850
- 2.1 Contributo in volume (Capitolo o Saggio) 22218
- 2.2 Prefazione/Postfazione 729
- 2.3 Breve introduzione 271
- 2.4 Voce (in dizionario o enciclopedia) 1046
- 2.5 Traduzione in volume 274
- 2.6 Recensione in volume 35
- 2.7 Schede di catalogo 277

3 Libro 4352
- 3.1 Monografia o trattato scientifico 3859
- 3.2 Concordanza 5
- 3.3 Indice 20
- 3.4 Bibliografia 24
- 3.5 Edizione critica 124
- 3.6 Pubblicazione di fonti inedite 14
- 3.7 Commento scientifico 54
- 3.8 Traduzione di libro 252

4 Contributo in Atti di Convegno (Proceeding) 25982
- 4.1 Contributo in Atti di convegno 19530
- 4.2 Abstract in Atti di convegno 5512
- 4.3 Poster 940

5 Altro 1817
- 5.01 Composizione 1
- 5.02 Disegno 1
- 5.03 Design 2
- 5.04 Performance 8
- 5.05 Esposizione 23
- 5.06 Mostra 33
- 5.07 Manufatto 1
- 5.08 Prototipo d'arte e relativi progetti 0
- 5.09 Cartografia 74
- 5.10 Banca dati 72
- 5.11 Software 29
- 5.12 Altro 1573

6 Brevetti 272
- 6.1 Brevetto 272

7 Curatele 1944
- 7.1 Curatela 1944

8 Tesi di dottorato 20
- 8.1 Tesi di dottorato 20

Prodotti recenti

Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial

Background Pre-clinical data suggest that docetaxel and enzalutamide interfere with androgen receptor translocation and signalling. The aim of this study is to assess the efficacy of their concurrent administration in the first-line treatment for metastatic castration-resistant prostate cancer (mCRPC). Methods In this open-label, randomised, phase II trial, previously untreated mCRPC patients were randomised 1:1 to receive eight 21-d courses of docetaxel 75 mg/m2, oral prednisone 5 mg twic...

Safety culture to improve accidental events reporting in radiotherapy

Background and purpose. The potential for unintended and adverse radiation exposure in radiotherapy (RT) is real and should be studied because RT is a highly complex, multistep process, which requires input from numerous individuals from different areas and steps of the RT workflow. The 'Incident' (I) is an event the consequence of which is not negligible from the point of view of protection or safety. A 'near miss' (NM) is defined as an event that is highly likely to happen but did not occu...

Diagnostic protocols in oncology: workup and treatment planning. Part 1: the optimitation of CT protocol

The increase in oncology knowledge and the possibility of creating personalized medicine by selecting a more suitable therapy related to tumor subtypes, as well as the patient's management with cancer within a multidisciplinary team has improved the clinical outcomes. Early detection of cancer through screening-based imaging is probably the major contributor to a reduction in mortality for certain cancers. Nowadays, imaging can also characterize several lesions and predict their histopatholog...

Diagnostic protocols in oncology: workup and treatment planning. Part 2: Abbreviated MR protocol

: Magnetic resonance imaging (MRI) is a non-invasive imaging technique (non-ionizing radiation) with superior soft tissue contrasts and potential morphological and functional applications. However, long examination and interpretation times, as well as higher costs, still represent barriers to MRI use in clinical routine. Abbreviated MRI protocols have emerged as an alternative to standard MRI protocols. Abbreviated MRI protocols eliminate redundant sequences that negatively affect cost, acqui...

Impact of smoking on COVID-19 outcomes: a HOPE Registry subanalysis

Background Smoking has been associated with poorer outcomes in relation to COVID-19. Smokers have higher risk of mortality and have a more severe clinical course. There is paucity of data available on this issue, and a definitive link between smoking and COVID-19 prognosis has yet to be established. Methods We included 5224 patients with COVID-19 with an available smoking history in a multicentre international registry Health Outcome Predictive Evaluation for COVID-19 (NCT04334291). Patien...

Scopri

Accesso al fulltext

no fulltext124956
reserved12188
open5657
partially open660
restricted7